• Skip to primary navigation
  • Skip to content
  • Skip to footer navigation
Aucta Pharma

Aucta Pharma

  • About Aucta
    • Aucta Introduction
    • Aucta Values
    • Aucta Vision
    • Management Team
  • Strategy
    • Strategy
    • R&D
    • Commercial
    • Manufacturing
  • Product Portfolio
    • Pipeline
    • Branded Products
    • Generic Products
    • Partnered Products
    • Partnering
  • Therapeutic Area
    • Therapeutic Area
    • Central Nervous System
    • Orphan and Specialty
  • Investors
    • Investors
    • Press Release/News
  • Working at Aucta
    • Careers
    • Employee Value Propostion
  • Contact Us
  • English
    • 简体中文
  • Pipeline
  • Branded Products
  • Generic Products
  • Partnered Products
  • Partnering
 
The first and only once-daily formulation of lacosamide
MOTPOLY XR marks a major milestone for Aucta as our 1st branded pharmaceutical product to enter the US market. It will be promoted through a new commercial infrastructure, available through retail pharmacies.

PATIENT

WEBSITE

HEALTHCARE PROFESSIONAL

WEBSITE

  • About Aucta
  • Strategy
  • Product Portfolio
  • Therapeutic Area
  • Investors
  • Contact Us
  • English
Address:71 Suttons Lane, Piscataway, New Jersey 08854 • Phone: +1 (732) 640-0030 • Privacy Policy •  • CA Disclosure